Tag: GLP1
Head-to-head trial shows Eli Lilly’s oral GLP-1 orforglipron outperforms oral semaglutide
A recent clinical trial compared two oral medications, orforglipron by Eli Lilly and oral semaglutide by Novo Nordisk,…
How GLP-1 use and eating disorders intersect
GLP-1 medications have undoubtedly revolutionized the field of medical weight management in a remarkably short period of time.…
New GLP-1 weight-loss drugs are coming—and they’re stronger than Wegovy and Zepbound
But some health professionals worry about the potential downsides of these powerful weight-loss medications. Dr. Carla Ramirez, an…
Here’s What Happens When You Stop GLP-1 Weight Loss Drugs
Challenges of Weight Loss Medication Adherence and Insurance CoverageHigh patient out-of-pocket costs and side effects are significant factors…
Humana’s CenterWell Pharmacy Launches Employer Venture Using Lilly’s GLP-1 Drugs
Humana’s CenterWell pharmacy has announced a new program in collaboration with Eli Lilly and Company to dispense GLP-1…
Stopping GLP-1 Drugs Triggers Weight Regain 4x Faster Than Ending Exercise : ScienceAlert
New Research Shows Rapid Weight Gain After Stopping Weight-Loss Drugs A recent study revealed that individuals who discontinue…
Why the weight, and heart risks, return after stopping GLP-1 drugsStopping obesity drugs means people regain weight and lose heart health benefitsÂ
Elizabeth Cooney, a cardiovascular disease reporter at STAT, delves into the complex world of weight loss drugs and…
Wegovy Pill Becomes First Oral GLP-1 Weight-Loss Drug Approved in U.S.
The U.S. has approved a groundbreaking weight-loss pill called Wegovy, which could potentially transform the healthcare industry. This…
The potential of GLP-1 drugs to transform medicine exploded in 2025
In 2025, the landscape of medicine was forever changed by the emergence of drugs such as Mounjaro, Wegovy,…
World Health Organization Recommends GLP-1 Drugs Like Ozempic For Obesity. Here’s What To Know
Obesity is a global epidemic that affects over a billion people worldwide, leading to serious health conditions such…
WHO Unveils GLP-1 Guidelines | Scientific American
The World Health Organization (WHO) has recently released new guidelines for the use of GLP-1 weight-loss drugs in…
GLP-1 Pill Fails to Slow Alzheimer’s Progression in Clinical Trial
The recent failure of Novo Nordisk's GLP-1 pill, semaglutide, to slow down the progression of Alzheimer's disease has…